Dream Tech has been spun out to develop a better method for conducting risk assessments on food, pharmaceuticals and pesticides.

Indiana University disclosed the launch of a US-based biotech spinout called Dream Tech on Monday, formed to commercialise a more dependable system for conducting regulatory risk assessments. The research uses a Bayes estimator, a probabilistic concept that can compensate for the lack of demonstrative evidence when making predictions, in a bid to tighten the assessment…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.